Tambong, Marilou .
HRN: 27-85-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/25/2025
10/02/2025
IV
600mg
Q 6h
DM Foot, Right
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines